If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRAV.L Regulatory News (RAV)

  • There is currently no data for RAV

Interim Management Statement

12 Nov 2012 07:00

RNS Number : 8162Q
Raven Russia Limited
12 November 2012
Ā 



12 November 2012

Ā 

Raven Russia Limited ("Raven Russia" or the "Company")

Ā 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1 JULY 2012Ā TO 12 NOVEMBER 2012

Ā 

Ā 

Key Highlights

Ā 

Ā·; Annualised, consolidated NOI now $168 million, increasing to $170 million including Letters of Intent ("LOIs")

Ā 

Ā·; Portfolio 95% let

Ā 

Ā·; Construction commenced on new build of 19,000 sqm at Noginsk and 30,000 sqm at Klimovsk phase 3 projects, for delivery Q2 2013

Ā 

Ā·; Preparatory work commenced on the Padikovo project

Ā 

Ā·; Construction financed by a $30m facility with DEG bank, drawn at end of October

Ā 

Ā·; Refinancing of Klimovsk phase 2 project to complete this quarter

Ā 

Ā·; Terms agreed to refinance Krekshino and Constanta projects

Ā 

Ā·; Tender offer buy back at 75p fully subscribed and completed on 26 October 2012

Ā 

Ā·; Group cash balance currently $156 million

Ā 

Ā 

Overview

Ā 

The letting market in our sector remains strong as we head towards the year end. We expect our assets in Moscow, St Petersburg and Rostov to be virtually fully let by 31 December. Novosibirsk is the slowest of the markets we operate in but continues to show steady interest.

Ā 

At today's date, we have annualised net operating income ("NOI") of $168 million, increasing to $170 million including LOIs and to $177 million when fully let.

Ā 

We have now turned to a managed development programme of our Moscow land bank and have commenced construction of 49,000 square metres ("sqm") of new space: 19,000 sqm at our Noginsk project; and 30,000 sqm at our Klimovsk project. As these are new phases of existing sites, the total marginal cost of construction is budgeted at $35 million, with delivery expected at the end of Q2 2013.

Ā 

The completion of these phases is expected to add $6.1 million of potential NOI to the portfolio.

Ā 

Preparatory work, which will enable a further 36,000 sqm of construction at the sites, is being completed in parallel.

Ā 

We have also commenced detailed planning work for our site at Padikovo, on the Nova Riga highway, North West Moscow, which was purchased in July this year. This will allow us to commence construction on that site in the second half of 2013, if the market remains strong.

Ā 

Ā 

Financial

Ā 

Our focus in the second half of this year has been on refinancing near term bank maturities. Terms have been agreed on the refinancing of the facility secured on our Krekshino asset, which matures in January 2013. The new facility is for $100 million, with a 7 year term. We expect this facility to be finalised this quarter.

Ā 

We have agreed terms to roll over the existing facility secured on our Constanta asset for a further 2 years.

Ā 

There are two new facilities completing in the second half of this year. We have drawn an unsecured construction loan of $30 million from DEG bank on an 8 year term, to fund the construction programme described earlier. As an unsecured construction loan, this has a higher cost of debt of 9% than our secured facilities.

Ā 

The second phase of our Klimovsk project is being used as security on another new facility of $47.5 million with a 10 year term and total expected cost of debt of just over 7%. All facility documents have been signed and we are awaiting confirmation of the registration of the mortgage before drawing.

Ā 

The tender offer buy back of 1 in 49 shares at 75p announced on 11 September 2012 was fully subscribed and 12,277,785 shares were purchased on 26 October 2012 and subsequently cancelled.

Ā 

Following the draw down of the DEG facility and tender offer buy back, the Group's cash balance is $156 million.

Ā 

Glyn Hirsch, Chief Executive of Raven Russia said:

Ā 

"We now have a mature portfolio of high yielding assets. To continue our steady growth, we are using our cash resources to develop selectively our Moscow land bank."

Ā 

Ā 

Enquiries

Ā 

Raven Russia Limited Tel: + 44 (0) 1481 712955

Anton Bilton

Glyn Hirsch

Ā 

Cardew Group Tel:+44 (0) 207 930 0777

Tim Robertson

Alexandra Stoneham

Ā 

N+1 Singer Tel: +44 (0) 203 205 7500

Corporate Finance- James Maxwell

Sales - Alan Geeves / James Waterlow

Ā 

This announcement contains forward-looking statements that involve risk and uncertainties and speak only as at the date of this announcement. The Group's actual results could differ materially from those estimated or anticipated in the forward-looking statements as a result of many factors. Information contained in this announcement relating to the Company should not be relied upon as a guide to future performance.

Ā 

About Raven Russia

Ā 

Raven Russia was founded in 2005 to invest in class A warehouse complexes in Russia and lease to Russian and International tenants. Its Ordinary Shares and Warrants are listed on the Main Market of the London Stock Exchange with a market capitalisation of approximately £350 million. The company operates out of offices in Guernsey, Moscow and Cyprus and has to date completed a portfolio of circa 1.3 million square metres of Grade "A" warehouses in Moscow, St Petersburg, Rostov-on-Don and Novosibirsk. For further information visit the Company's website: www.ravenrussia.com

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
IMSLLFVRLRLAIIF
Date   Source Headline
3rd Mar 20117:00 amRNSScrip Dividend Circular
1st Mar 20117:00 amRNSTotal Voting Rights
28th Feb 20117:00 amRNSAcquisition
17th Feb 20114:21 pmRNSPreference Share Dividend - Replacement
17th Feb 20117:00 amRNSPreference Share Dividend
14th Feb 20117:01 amRNSChange of Joint Broker
14th Feb 20117:00 amRNSChange of Nominated Adviser
2nd Feb 20117:00 amRNSBlock Listing Six Monthly Return
1st Feb 20117:00 amRNSTotal Voting Rights
11th Jan 20115:40 pmRNSDirector/PDMR Shareholding
7th Jan 20117:00 amRNSIssue of Preference Shares
4th Jan 20117:00 amRNSTotal Voting Rights
31st Dec 20107:00 amRNSDirector/PDMR Shareholding
30th Dec 20107:00 amRNSIssue of Preference Shares
15th Dec 20109:37 amRNSDirector/PDMR Shareholding
10th Dec 20103:35 pmRNSDirector/PDMR Shareholding
2nd Dec 20107:00 amRNSScrip Dividend Circular
1st Dec 20107:00 amRNSVoting Rights and Capital
24th Nov 20105:36 pmRNSDirector/PDMR Shareholding
19th Nov 20107:00 amRNSInterim Management Statement
18th Nov 20107:00 amRNSPreference Share Dividend
11th Nov 20103:24 pmRNSDirector/PDMR Shareholding
10th Nov 20109:37 amRNSHolding(s) in Company
1st Nov 20107:00 amRNSVoting Rights and Capital
27th Oct 20101:53 pmRNSHolding(s) in Company
26th Oct 20107:00 amRNSDirector/PDMR Shareholding
26th Oct 20107:00 amRNSDirector/PDMR Shareholding
26th Oct 20107:00 amRNSVoting Rights and Capital
26th Oct 20107:00 amRNSVoting Rights and Capital
20th Oct 20105:32 pmRNSDirector/PDMR Shareholding
20th Oct 20105:32 pmRNSDirector/PDMR Shareholding
14th Oct 20109:07 amRNSDirector/PDMR Shareholding
13th Oct 20109:21 amRNSHolding(s) in Company
30th Sep 20109:25 amRNSDirector/PDMR Shareholding
30th Sep 20107:00 amRNSVoting Rights and Capital
29th Sep 20104:00 pmRNSUpdate re Tender Offer and Notice of EGM
29th Sep 20107:00 amRNSIssue of Preference Shares
28th Sep 20106:04 pmRNSResult of Written Resolution
17th Sep 20104:34 pmRNSDirector/PDMR Shareholding
15th Sep 20104:37 pmRNSDirector/PDMR Shareholding
6th Sep 20109:08 amRNSAmendments to Warrant Instrument
2nd Sep 20107:00 amRNSScrip Dividend Circular
1st Sep 20104:18 pmRNSHolding(s) in Company
31st Aug 20107:00 amRNSHalf Yearly Report
31st Aug 20107:00 amRNSVoting Rights and Capital
26th Aug 20103:26 pmRNSNotice of Results
19th Aug 20102:54 pmRNSPreference Share Dividend
16th Aug 20103:37 pmRNSHolding(s) in Company
12th Aug 20101:50 pmRNSHolding(s) in Company
5th Aug 20105:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.